rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-7-2
|
pubmed:abstractText |
We sought to determine both the procedural performance and safety of percutaneous implantation of the second (21-French [F])- and third (18-F)-generation CoreValve aortic valve prosthesis (CoreValve Inc., Irvine, California).
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1558-3597
|
pubmed:author |
pubmed-author:BonanRaoulR,
pubmed-author:BuellesfeldLutzL,
pubmed-author:CartierRaymondR,
pubmed-author:FelderhoffThomasT,
pubmed-author:GerckensUlrichU,
pubmed-author:GrubeEberhardE,
pubmed-author:IversenSteinS,
pubmed-author:LinkeAxelA,
pubmed-author:MohrFriedrich-WilhelmFW,
pubmed-author:SaurenBarthelB,
pubmed-author:SchulerGerhardG,
pubmed-author:WaltherThomasT,
pubmed-author:WenaweserPeterP,
pubmed-author:ZickmannBernfriedB
|
pubmed:issnType |
Electronic
|
pubmed:day |
3
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
69-76
|
pubmed:dateRevised |
2008-2-5
|
pubmed:meshHeading |
pubmed-meshheading:17601548-Age Factors,
pubmed-meshheading:17601548-Aged,
pubmed-meshheading:17601548-Aged, 80 and over,
pubmed-meshheading:17601548-Aortic Valve Stenosis,
pubmed-meshheading:17601548-Bioprosthesis,
pubmed-meshheading:17601548-Female,
pubmed-meshheading:17601548-Follow-Up Studies,
pubmed-meshheading:17601548-Heart Catheterization,
pubmed-meshheading:17601548-Heart Valve Prosthesis Implantation,
pubmed-meshheading:17601548-Humans,
pubmed-meshheading:17601548-Male,
pubmed-meshheading:17601548-Prospective Studies,
pubmed-meshheading:17601548-Prosthesis Design,
pubmed-meshheading:17601548-Risk Assessment,
pubmed-meshheading:17601548-Severity of Illness Index,
pubmed-meshheading:17601548-Single-Blind Method,
pubmed-meshheading:17601548-Survival Rate,
pubmed-meshheading:17601548-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome.
|
pubmed:affiliation |
HELIOS Heart Center Siegburg, Siegburg, Germany. GrubeE@aol.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|